NVLN

Novelion Therapeutics Inc. Common Shares
NVLN

Overview Fund Activity
Delisted

NVLN was delisted on the 8th of October, 2019.

Back to rankings

68 hedge funds and large institutions have $53.1M invested in Novelion Therapeutics Inc. Common Shares in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
-14
Holders Change %
-17.07%
% of All Funds
1.56%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
2
Increased
15
Reduced
20
Closed
16
Calls
$69K
Puts
$149K
Net Calls
-$80K
Net Calls Change
-$27K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$1.46M
2
SCM
Stonepine Capital Management
Oregon
+$578K
3
State Street
State Street
Massachusetts
+$94.5K
4
PAM
Panagora Asset Management
Massachusetts
+$54K
5
PPA
Parametric Portfolio Associates
Washington
+$53.4K

Top Sellers

1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$644K
2
PM
Prosight Management
Texas
-$222K
3
OAM
Oxford Asset Management
United Kingdom
-$138K
4
VF
Virtu Financial
New York
-$138K
5
Charles Schwab
Charles Schwab
California
-$134K
Name Holding Trade Value Shares
Change 		Shares
Change %
Russell Investments Group
76
Russell Investments Group
United Kingdom
– -$5K -1,600 Closed
BC
77
Bartlett & Co
Ohio
– -$1K -400 Closed
1 2 3
4